Dupont Capital Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Dupont Capital Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,666	Closed	-$13K	–	1837
2022 Q1	$13K	Hold	16,666	–	–	﹤0.01%	1490
2021 Q4	$10K	Hold	16,666	–	–	﹤0.01%	1613
2021 Q3	$16K	Hold	16,666	–	–	﹤0.01%	1579
2021 Q2	$23K	Buy	+16,666	New	+$14.5K	﹤0.01%	1577

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Dupont Capital Management's PEARW Position: Q2 2022 in Review

Dupont Capital Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2022, closing a stake of 16,666 shares — an estimated $13K sold.

Dupont Capital Management first reported a position in PEARW in Q2 2021 and held it in 4 quarters. The position peaked at $23K in Q2 2021. 37 funds tracked by Wall St. Rank hold PEARW as of Q2 2022.

Dupont Capital Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
Dupont Capital Management sold 16,666 Pear Therapeutics, Inc. Warrant shares in Q2 2022, an estimated $13K.
Dupont Capital Management first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 4 quarters.
Dupont Capital Management's Pear Therapeutics, Inc. Warrant position peaked at $23K in Q2 2021.
37 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.